Last updated at 23 Jun 2024 11:43 PM
Director
DIN: 03303607
Avinash A Kenkare is currently associated with 2 companies as Director. They serve as a Director at GENWORKS HEALTH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03303607.Avinash A Kenkare has previously been associated with 12 companies in roles such as Director, Additional Director and Nominee Director.Avinash A Kenkare is currently involved in 1 different role. Their most recent position is with PRINTMANN OFFSET PRIVATE LIMITED CN as a Director. The first company Avinash A Kenkare was appointed to as a director was GENWORKS HEALTH PRIVATE LIMITED. Avinash A Kenkare is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Avinash A Kenkare is currently associated with 2 companies as Director. They serve as a Director at GENWORKS HEALTH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03303607.Avinash A Kenkare has previously been associated with 12 companies in roles such as Director, Additional Director and Nominee Director.Avinash A Kenkare is currently involved in 1 different role. Their most recent position is with PRINTMANN OFFSET PRIVATE LIMITED CN as a Director. The first company Avinash A Kenkare was appointed to as a director was GENWORKS HEALTH PRIVATE LIMITED. Avinash A Kenkare is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (12)
3 Years 1y 6m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
GENWORKS HEALTH PRIVATE LIMITED | Director | 15-Nov-2019 |
PRINTMANN OFFSET PRIVATE LIMITED CN | Director | 20-Feb-2024 |